ArticleCancers2022

Prognostic Potential of the Baseline Pan-Immune-Inflammation Value and Neutrophil/Lymphocyte Ratio in Stage I to III Melanoma Patients.

Thilo Gambichler et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.